Diseases of the Veins and Arteries: Leg Ulcers

Rook's Textbook of Dermatology: Eighth Edition

Volumn 3, Issue , 2010, Pages 2195-2252

  Mortimer, Peter S ^a,b,e   Burnand, Kevin G ^c   Neumann, H A Martino ^d  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Arterial and arteriolar disorders; Arterial disease and peripheral ischaemic disorders arterial disease; Ataxia telangiectasia, rare autosomal recessive disease with pleiotropic involvement of nervous and lymphoid systems; Contact dermatitis skin around ulcer becoming red and sore; Deep vein incompetence secondary venous incompetence; Diseases of veins and arteries leg ulcers; Light reflection rheography and digital photoplethysmography; Neurovascular disorders of extremities; Small vessel calcification and calcific uraemic arteriolopathy (calciphylaxis); Stewart Bluefarb syndrome

Indexed keywords

EID: 84865287585     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch47     Document Type: Chapter

References (578)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 677-84.
3. Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations and molecular dimensions. Am J Med Genet Part A 2006; 140A: 2013-38.
4. De Maeseneer MG, Vandenbroeck CP, Lauwers PR et al. Early and late complications of silicone patch saphenoplasty at the saphenofemoral junction. J Vasc Surg 2006; 44: 1285-90.
5. Simons M. Angiogenesis. Circulation 2005; 111: 1556-66.
6. Hansson GK. Mechanisms of disease: inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
7. Hill JM, Zalos G, Halcox JPJ et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
8. Woolf N, ed. Pathology of Atherosclerosis. London: Butterworth,1982.
9. Dormandy JA, Stock G, eds. Critical Leg Ischaemia: its Pathology and Management. Berlin: Springer-Verlag,1990.
10. Browse NL, Burnand KG, Irvine AJ, Wilson NM. Diseases of the Veins, 2nd edn. London: Arnold,1999.
11. Rutherford RB, ed. Vascular Surgery. Philadelphia: Elsevier Saunders,2005.
12. Norgren L, Hiatt WR et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Endovasc Surg 2007; 33 (Suppl.): 5-75.
13. Kar P, Laight D, Shaw KM, Cummings MH. Flavonoid-rich grapeseed extracts:a new approach in high cardiovascular rich patients? Int J Clin Pract 2006; 60:1484-92.
14. Insall RL, Davies RJ, Prout WG. Significance of Buerger's test in the assessment of lower limb ischaemia. J R Soc Med 1989; 82: 729-31.
15. Summer SD, Strandness DE. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication. Surgery 1969; 65: 763-5.
16. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006; 295:536-46.
17. Clyne CAC, Ramsden WH, Chant ADB et al. Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg 1985; 72: 644-7.
18. Franzeck UK, Talke P, Bernstein EF et al. Transcutaneous Po2 measurements in health and peripheral arterial occlusive disease. Surgery 1982; 91: 156-63.
19. Neumann HA, Van den Broek MJ, Boersma IH, Veraart JC. Transcutaneous oxygen tension in patients with and without pericapillary fibrin cuffs in chronic venous insufficiency, porphoria cutanea tarda and non-venous leg ulcers. Vasa 1996; 25: 127-33.
20. Alpert JS, Garcia del Rio H, Lassen NA. Diagnostic use of radioactive xenon clearance and a standardised walking test in obliterative arterial disease of the legs. Circulation 1966; 34: 849-55.
21. Koelemay MJW, Den Hartog D, Prins MH et al. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg 1996; 83: 404-9.
22. Legemate DA, Teeuwen C, Hoeneveld H et al. The potential of duplex scanning to replace aorto-iliac and femoro-popliteal angiography. Eur J Vasc Surg 1989; 3: 49-54.
23. Friedman SG, Moccio CG. A prospective comparison of intra-arterial digital subtraction and conventional angiography prior to lower extremity revascularisation. J Cardiovasc Surg 1989; 30: 462-6.
24. Olin JW, Shih A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 2006; 18: 18-24.
25. Lagattolla NRF, Burnand KG, Stewart A. Role of transoesophageal echocardiography in determining the source of peripheral arterial embolism. Br J Surg 1995; 82: 1651-4.
26. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-99.
27. Canadian Cooperative Study Group. A randomised trial of aspirin and sulphinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-9.
28. Imparato AM, Kim GE, Davison T et al. Intermittent claudication: its natural course. Surgery 1975; 119: 75-8.
29. Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Medical management of peripheral arterial disease. J Thromb Haemost 2005; 3: 1628-37.
30. Dormandy JA, Stock G, eds. Critical Leg Ischaemia: its Pathology and Management. Berlin: Springer-Verlag,1990.
31. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295: 547-53.
32. Grüntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with Grüntzig balloon catheter. Am J Roentgenol 1979; 132: 547-52.
33. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Eng J Med 2006; 354: 1879-88.
34. White C. Intermittent claudication. N Engl J Med 2007; 356: 1241-50.
35. De Weese JA, Rob CG. Autogenous venous bypass grafts 5 years later. Ann Surg 1971; 174: 346-56.
36. Tyson RR, Reichle FA. Femorotibial bypass. Ann Surg 1969; 170: 429-34.
37. Haxton HA. Chemical sympathectomy. BMJ 1949; 1: 1026-8.
38. Veith FJ, Gupta SK, Samson RH et al. Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures. Ann Surg 1981; 194: 386-401.
39. Cotton LT, Cross FW. Lumbar sympathectomy for arterial disease. Br J Surg 1985; 72: 678-83.
40. Norgren L, Alwmark A, Angqvist KA et al. A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb: a Scandinavian-Polish placebo controlled randomised multicenter study. Eur J Vasc Surg 1990; 4: 463-7.
41. Federman DG, Kravetz JD. Peripheral arterial disease: diagnosis, treatment, and systemic implications. Clin Dermatol 2007; 25: 93-100.
42. Burnand KG, Layer G, Whitehead S et al. Critical ischaemia of the lower limb:can we save more limbs from amputation? J Cardiovasc Surg 1990; 31 (Suppl.):77 (Abstract).
43. Ouriel K, Shortell CK, De Weese JA et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischaemia. J Vasc Surg 1994; 19: 1021-30.
44. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908; 136: 567-80.
45. Totemchokchyakarn K. Thromboangiitis obliterans (Buerger's disease). In: Ball GV, Bridges SL, eds. Vasculitis. Oxford: Oxford University Press, 2002: 460-6.
46. Wessler S. Buerger's disease revisited. Surg Clin North Am 1969; 49: 703-13.
47. Olin JW, Smith A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 2006; 18: 18-24.
48. Adar R, Papa MJ, Halpern Z et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983; 308: 1113-6.
49. Shionoya S. Pathology of Buerger's disease, clinico-pathico-angiographic correlation. Pathol Microbiol 1975; 43: 163-6.
50. Puéchal X, Fiessinger J-N. Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology 2007; 46: 192-9.
51. Lazarides MK, Georgiadis GS, Papas TT, Nikolopoulos ES. Diagnostic criteria and treatment of Buerger's disease: a review. Int J Low Extrem Wounds 2006; 5: 89-95.
52. Ohta T, Shionoya S. Fate of the ischaemic limb in Buerger's disease. Br J Surg 1988; 75: 259-62.
53. Fiessinger JN, Schäfer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis. Lancet 1990; i: 555-7.
54. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg 2005; 41: 830-6.
55. Chan YL, Mahony JF, Turner JJ, Posen S. The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol 1983; 109: 85-95.
56. Brown GF. Erythromelalgia and other disturbances of the extremities accompanied by vasodilatation and burning. Am J Med Sci 1932; 183: 468-85.
57. Mitchell SW. A rare vasomotor neurosis of the extremities and on maladies with which it may be confounded. Am J Med Sci 1878; 76: 2-36.
58. Smith LA, Allen FV. Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat and pain. Am Heart J 1938; 16: 136-41.
59. Alarcon-Segovia D, Bag RR, Fairbain JF et al. Erythermalgia: a clue to early diagnosis of myeloproliferative disorders. Arch Intern Med 1966; 117: 511-5.
60. Michiels JJ, Abels J, Steketee J et al. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis. Ann Intern Med 1985; 102: 466-71.
61. Michiels JJ, Van Joost T. Erythromelalgia and thrombocythemia: a causal relation. J Am Acad Dermatol 1990; 22: 107-11.
62. Redding KG. Thrombocythaemia as a cause of erythermalgia. Arch Dermatol 1977; 113: 448-71.
63. Michiels JJ, Van Joost TH, Vuzevski VD et al. Histopathology of erythromelalgia in thrombocythaemia. Histopathology 1984; 8: 669-78.
64. Michiels JJ, Van Joost TH, Vuzevski VD. Idiopathic erythermalgia: a congenital disorder. J Am Acad Dermatol 1989; 21: 1128-30.
65. Drenth JP, Finley WH, Breedveld GJ et al. The primary erythermalgia: susceptibility gene is located on chromosome 2q 31-2. Am J Hum Genet 2001; 68: 1277-82.
66. Waxman SG, Dib-Hajj SD. Erythromelalgia: a hereditary pain syndrome enters the molecular era. Ann Neurol 2005; 57: 785-8.
67. Waxman SG, Dib-Hajj SD. Molecular basis for an inherited pain syndrome. Trends Mol Med 2005; 11: 555-62.
68. Davis MDP, Sandroni P, Rooke TW, Low PA. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol 2003; 139: 1337-43.
69. Han C, Lampert A, Rush AM et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav 1.7. Mol Pain 2007; 3: 3.
70. Babb RR, Alarcon-Segovia D, Fairbain JF. Erythermalgia: review of 51 cases. Circulation 1964; 29: 136-41.
71. Ørstavik K, Mørk C, Kvernebo K, Jørum E. Pain in primary erythromelalgia-a neuropathic component? Pain 2004; 110: 531-8.
72. Davis MD, Fallon WM, Rogers RS III et al. Natural history of erythromelalgia:presentation and outcome of 168 patients. Arch Dermatol 2000; 136: 330-6.
73. Alarcon-Segovia D, Diaz-Jouananen E. Erythermalgia in systemic lupus erythematosus. Am J Med Sci 1973; 266: 149-51.
74. Ratz JI, Berfield WF, Steck WD. Erythermalgia with vasculitis. J Am Acad Dermatol 1979; 1: 433-50.
75. Sandroni P, Davis MDP, Harper CM Jr et al. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromusc Dis 1999; 1: 57-63.
76. Drenth JPH. Erythromelalgia induced by nicardipine. BMJ 1989; 298: 1582.
77. Levesque H, Moore N, Wolf LM et al. Erythromelalgia induced by nicardipine (inverse Raynaud's phenomenon). BMJ 1989; 298: 1252-3.
78. Davis MD, Rooke T. Erythromelalgia. Curr Treat Options Cardiovasc Med 2006; 8:153-65.
79. Michiels JJ, Lindemans J, Van Vliet HHDM et al. Survival kinetics of platelets and fibrinogen in thrombocythaemia related to erythromelalgia. Br J Haematol 1982; 50: 690-1.
80. Bada SL. Treatment of erythromelalgia with propranolol. Lancet 1977; ii:412.
81. Le Noach E, Guillet MH, Sassolas B et al. Erythromelalgie familiale; une observation traitée avec succes par pizotifene. Ann Dermatol Vénéréol 1994; 121 (Suppl. 1): 563.
82. Cimaz R, Rusconi R, Fossali E et al. Unexpected healing of cutaneous ulcers in a short child. Lancet 2001; 358: 211-2.
83. Davis MDP, Sandroni P. Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients. Arch Dermatol 2005; 141: 1320-1.
84. Eisenberg E, Geller R, Brill S. Pharmacotherapy options for complex regional pain syndrome. Expert Rev Neurother 2007; 5: 521-31.
85. Jänig W, Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol 2003; 2: 687-97.
86. Harden RN, Bruehl SP. Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria. Clin J Pain 2006; 22:415-9.
87. Wasner G, Schattschneider J, Heckmann K et al. Vascular abnormalities in the reflex sympathetic dystrophy (CRPS 1): mechanisms and diagnostic value. Brain 2001; 124: 587-99.
88. Driessens M, Dijs H, Verheyen G, Blockx P. What is reflex sympathetic dystrophy? Acta Orthop Belg 1999; 65: 202-17.
89. Atkins RM. Aspects of current management: complex regional pain syndrome. J Bone Joint Surg 2003; 85-B: 1100-6.
90. Sharma A, Williams K, Raja SN. Advances in treatment of complex regional pain syndrome: recent insights on a perplexing disease. Curr Opin Anaesthesiol 2006; 19: 566-72.
91. Perez RSGM, Zuurmond WWA, Bezemer PD et al. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study. Pain 2003; 102: 297-307.
92. Warltier DC. Preventing the development of complex regional pain syndrome after surgery. Anesthesiology 2004; 101: 1215-24.
93. Hassantash SA, Afrakhteh M, Maier RV. Causalgia. A meta-analysis of the literature. Arch Surg 2003; 138: 1226-31.
94. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med 2007; 120 (Suppl. 1A): 4-12.
95. Allen RP. Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med 2007; 120 (Suppl. 1A): 13-21.
96. Winkelmann J, Ferini-Strambi L. Genetics of restless legs syndrome. Sleep Med Rev 2006; 10: 179-83.
97. Earley CJ. Restless legs syndrome. N Engl J Med 2003; 348: 2103-9.
98. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005; 4: 464-75.
99. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10: 153-67.
100. Hening WA. Current guidelines and strategies of practice for restless legs syndrome. Am J Med 2007; 120 (Suppl. 1A): 22-7.
101. Kennedy C, Bastiaens MT, Bajdik CD et al. Effect of smoking and sun on the ageing skin. J Invest Dermatol 2003; 120: 548-54.
102. Bergan JJ, Goldman MP. Varicose Veins and Telangiectasias. St. Louis: Quality Medical Publishing,1993.
103. Duffy DM. Small vessel sclerotherapy: an overview. In: Callen JP. et al., eds. Advances in Dermatology, Vol. 3. Chicago: Year Book Medical Publishers, 1988: 221.
104. Van der Molen HR. Die Corona Phlebectatica Paraplantaris. Der Fuss, 1982:154-74.
105. Thornton CM, Eichenfield LF, Shinall EA et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol 1995; 33: 19-25.
106. Thériault G, Cordier S, Harvey R. Skin telangiectases in workers at an aluminium plant. N Engl J Med 1980; 303: 1278-81.
107. Fallo T, Abell E, Kingsley L et al. Telangiectasias of the anterior chest in homosexual men. Ann Intern Med 1986; 105: 679-82.
108. Ruiz-Avila P, Tercedor J. Painful periungual telangiectasias in a patient with acquired immunodeficiency syndrome. Int J Dermatol 1995; 34: 199-200.
109. Ozguroglu E, Buyulbabani N, Ozguroglu M et al. Generalised telangiectasia as the major manifestation of angiotropic (intravascular) lymphoma. Br J Dermatol 1997; 137: 422-5.
110. Bean WB. Vascular Spiders and Related Lesions of the Skin. Springfield: Thomas,1958.
111. Wenzl JE, Burgess EO. The spider nevus in infancy and childhood. Pediatrics 1964; 33: 227-32.
112. Whiting DA, Kallmeyer JC, Simson IW. Widespread arterial spiders in a case of latent hepatitis, with resolution after therapy. Br J Dermatol 1970; 82: 32-6.
113. Martini GA, Staubesand J. Zur Morphologie des Gefässpinnen ('vascular spiders') in der Haut Leberkranker. Virchows Arch Path Anat Physiol 1953; 324: 147-64.
114. Weedon D. Vascular tumor. In: Weedon D, ed. Skin Pathology, 2nd edn. London:Churchill Livingstone,2002.
115. Cunliffe WJ, Dodman B, Butterworth MJ. Unilateral spider naevi. Br J Dermatol 1972; 87: 51-2.
116. Bean WB. Vascular Spiders and Related Lesions of the Skin. Springfield: Thomas,1958.
117. Stehbens WE, Ludatscher RM. Fine structure of senile angiomas of human skin. Angiology 1968; 19: 581-92.
118. Braverman IM. Ultrastructure and organisation of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989; 93 (Suppl. 2):25-95.
119. Mittal R, Aggarwal A, Srivastava G. Angiokeratoma circumscriptum: a case report and review of the literature. Int J Dermatol 2005; 44: 1031-4.
120. Basarab T, Yu R, Jones RR. Calcium antagonist-induced photo-exposed telangiectasia. Br J Dermatol 1997; 136: 974-5.
121. Karonen T, Stubb S, Keski-Oja J. Truncal telangiectases coinciding with felodipine. Dermatology 1998; 196: 272-3.
122. Grabczynska S, Cowley N. Amlodipine induced-photosensitivity presenting as telangiectasia. Br J Dermatol 2000; 142: 1255-6.
123. Ioulios P, Charalampos M, Efrossini T. The spectrum of cutaneous reactions with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms. Dermatology Online J 2003; 5: 6.
124. Cooper SM, Wojnarowska F. Photo-damage in Northern European renal transplant recipients is associated with use of calcium channel blockers. Clin Exp Dermatol 2003; 28: 588-91.
125. Bean WB, Walsh JR. Venous lakes. Arch Dermatol 1956; 74: 459-63.
126. Kocsard E, Ofner F, D'Abrera VS et al. The phlebectasis of old age-incidence and diagnostic importance. J Am Geriatr Soc 1970; 18: 31-8.
127. Clark ANG, Melcher DH, Hall-Smith P. Palmar and finger varicosities of the aged. Br J Dermatol 1974; 91: 305-14.
128. Duffy DM, Garcia C, Clark RE. The role of sclerotherapy in abnormal varicose hand veins. Plast Reconstr Surg 1999; 104: 1474-9.
129. Ramelet AA. Phlebectomy. Technique, indications and complications. Int Angiol 2002; 21 (Suppl. 1): 46-51.
130. Barker IP, Sachs PM. Angioma serpiginosum. Arch Dermatol 1965; 92: 613-20.
131. Frain-Bell W. Angioma serpiginosum. Br J Dermatol 1957; 69: 251-68.
132. Yaffee HS. Angioma serpiginosum. Arch Dermatol 1967; 95: 667.
133. Kumakiri M, Katoh H, Mitura Y et al. Angioma serpiginosum. J Cut Pathol 1980; 7: 410-21.
134. Marriott PJ, Munro DD, Ryan T. Angioma serpiginosum-familial incidence. Br J Dermatol 1975; 93: 701-6.
135. Cox NH, Paterson WD. Angioma serpiginosum: a simulator of purpura. Postgrad Medl J 1991; 67: 1065-6.
136. Ohnishi T, Nagayama T, Morita T et al. Angioma serpiginosum: a report of 2 cases identified using epiluminescence microscopy. Arch Dermatol 1999; 135:1366-8.
137. Gautier-Smith PC, Sanders MD, Sanderson KV. Ocular and nervous system involvement in angioma serpiginosum. Br J Ophthalmol 1971; 55: 433-43.
138. Long CC. Treatment of angioma serpiginosum using a pulsed tunable dye laser. Br J Dermatol 1997; 136: 631-2.
139. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary haemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-24.
140. Bayrak-Toydemir P, Mao R, Lewin S, McDonald J. Hereditary hemorrhagic telangiectasia:an overview of diagnosis and management in the molecular era for clinicians. Genet Med 2004; 6: 175-91.
141. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43: 97-110.
142. Fernàndez LA, Sanz-Rodriquez F, Blanco FJ et al. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-β signaling pathway. Clin Med Res 2006; 4: 66-78.
143. Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Gen 2000; 26: 328-31.
144. Muggia FM. Osler's disease with an aortic arch aneurysm. Arch Intern Med 1964; 114: 307-10.
145. Williams GA, Brick IB. Gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. Arch Intern Med 1955; 95: 41-51.
146. Harders H. The micromorphology and biomicroscopical diagnosis of Osler's disease. Bibl Anat 1965; 7: 523-9.
147. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987; 82: 989-97.
148. Purriel P, Muras O. Aneurisms arteriovenosus de pulmòn. Thorax 1957; 6:101-58.
149. Begbie ME, Wallace GMF, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad J Med 2003; 79: 18-24.
150. Landau J, Nelken E, Davis E. Hereditary haemorrhagic telangiectasia with retinal and conjunctival lesions. Lancet 1956; ii: 230-1.
151. Sabbà C. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost 2005; 3: 2201-10.
152. Perlman S, Becker-Catania S, Gatti RA. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 2003; 10: 173-82.
153. McKinnon PJ. ATM and ataxia telangiectasia. EMBO 2004; 5: 772-6.
154. Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 2000; 92: 170-7.
155. Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007; 6: 931-42.
156. Cohen LE, Tanner DJ, Schaeber HG et al. Common and uncommon cutaneous findings in patients with ataxia telangiectasia. J Am Acad Dermatol 1984; 10:431-8.
157. Joshi AK, Al Asiri RH, Haleem A et al. Cutaneous granuloma with ataxia telangiectasia-a case report and review of the literature. Clin Exp Dermatol 1993; 18:458-61.
158. Taylor AMR, Byrd PJ. Molecular pathology of ataxia telangiectasia. J Clin Pathol 2005; 58: 1009-15.
159. Chun HH, Sun X, Nahas S et al. Improved diagnostic testing for ataxia telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab 2003; 80: 437-43.
160. Bean WB, Rathe J. Universal angiomatosis. Arch Int Med 1963; 112: 869-74.
161. Fox TC. A case of bilateral telangiectasis of the trunk, with a history of marked epistaxis in childhood and recent rectal haemorrhage. Br J Dermatol 1908; 20:145-62.
162. McGrae JD, Winkelmann RK. Generalised essential telangiectasia. JAMA 1963; 185: 909-13.
163. Checketts SR, Burton PS, Bjorkman DJ, Kadunce DP. Generalized essential telangiectasia in the presence of gastrointestinal bleeding. J Am Acad Dermatol 1997; 37: 321-5.
164. Gamblichler T, Avermaete A, Wilmert M et al. Generalised essential telangiectasia successfully treated with high-energy, long-pulse, frequency-doubled Nd:YAG laser. Dermatol Surg 2001; 27: 355-7.
165. Hynes LR, Shenefelt PD. Unilateral nevoid telangiectasia: occurrence in two patients with hepatitis C. J Am Acad Dermatol 1997; 36: 819-22.
166. Creamer D, Clement M, McGregor JM, Hawk JL. Polymorphic light eruption occurring solely on an area of naevoid telangiectasia. Clin Exp Dermatol 1999; 24:202-3.
167. Zahorcsek Z, Schneider I. Hereditary benign telangiectasia. Dermatology 1994; 189:286-8.
168. Gold MH, Eramo L, Prendiville JS. Hereditary benign telangiectasia. Pediatr Dermatol 1989; 6: 194-7.
169. Ryan TJ, Wells RS. Hereditary benign telangiectasia. Trans St John's Hospital Dermatol Soc 1971; 57: 148-56.
170. Watanebe M, Tomita, Y, Tagami H. Hereditary benign telangiectasia-a congenital type. Dermatologica 1990; 181: 152-3.
171. Tsianakas P, Teillac-Hamel D, Fraitag S et al. Etude ultrastructurale des telangiectases héréditaires bénignes. Ann Dermatol 1995; 122: 517-21.
172. Onishi Y, Ohara K, Shikida Y, Satomi H. Hereditary benign telangiectasia: image analysis of hitherto unknown association with arteriovenous malformation. Br J Dermatol 2001; 145: 641-5.
173. Juhlin L, Olsson MJ. Naevus anaemicus with telangiectatic vessels. Eur J Dermatol 2001; 11: 518-20.
174. Requena L, Galvan C, Sanchez Yus E. Solitary plaque-like telangiectatic glomangioma. Br J Dermatol 1998; 139: 902-5.
175. Goldman MP, Bennett RG. Treatment of telangiectases: a review. J Am Acad Dermatol 1987; 17: 167-82.
176. Bergen JJ, Goldman MP. Varicose Veins and Telangiectases. St Louis: Quality Medical Publising,1993.
177. Gonzales E, Gange RW, Montaz KT. Treatment of telangiectases and other benign vascular lesions with the 577 nm pulsed dye laser. J Am Acad Dermatol 1992; 27: 220-6.
178. Railan D, Parlatte EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol 2006; 24: 8-15.
179. Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed 2006; 22: 324-32.
180. Schroeter CA, Wilder D, Reineke T et al. Clincal significance of an Intense Pulsed Light Source on leg telangiectasias of up to 1 mm diameter. Eur J Dermatol 1997; 7: 38-42.
181. Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia: effect of increasing concentrations of polidocanol. J Am Acad Dermatol 1989; 20: 683-9.
182. Haimovici H. Abnormal arteriovenous shunts associated with chronic venous insufficiency. J Cardiovasc Surg 1976; 17: 473-82.
183. Piulachs P, Vidal-Barraquer F. Pathogenic study of varicose veins. Angiology 1953; 4: 59-100.
184. Haimovici H, Steinman C, Caplan LH. Role of arteriovenous anastomoses in vascular diseases of the lower extremity. Ann Surg 1966; 164: 990-1002.
185. Myers MB, Cherry C. Pathophysiology and treatment of stasis ulcers of the leg. Am Surg 1971; 37: 167-74.
186. Ryan TJ. Arteriovenous pathways. In: Jarrett A, ed. The Physiology and Pathophysiology of the Skin. London: Academic Press, 1973: 586-91.
187. Bean WB, ed. Vascular Spiders and Related Lesions of the Skin. Springfield: Thomas,1958.
188. Haimovici H. Role of A-V shunting in varicose veins: therapeutic implications. J Cardiovasc Surg 1995; 36: 109-15.
189. Urbach F. The blood supply of tumors. In: Morgagna W, Ellis R, eds. Advances in Biology of Skin, Vol. 2. Oxford: Pergamon, 1961: 123-49.
190. Fairbairn JF II, Bernatz PF. Arteriovenous fistulas. In: Fairbairn JF II, Juergens JL, Spittell JA Jr, eds. Peripheral Vascular Diseases, 4th edn. Philadelphia: Saunders, 1972: 303-26.
191. Elkin DC, Warren JV. Arteriovenous fistulas: their effects on the circulation. JAMA 1947; 134: 1524-8.
192. Holman E, ed. Abnormal Arterivenous Communications: Peripheral and Intracardiac, Acquired and Congenital. Springfield: Thomas,1968.
193. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part 1. J Am Acad Dermatol 2007; 56: 353-62.
194. Eerola I, Boon LM, Mulliken JB et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73: 1240-9.
195. Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med 1998; 8: 281-92.
196. Enjolras O, Logeart I, Gelbert F et al. Malformations artérioveineuses: étude de 200 cas. Ann Dermatol Venereol 1999; 127: 17-22.
197. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 1998; 102: 643-54.
198. Komiyama M, Khosla VK, Yamamoto Y, Toyota N. Embolization in high-flow arteriovenous malformations of the face. Ann Plast Surg 1992; 28: 575-83.
199. Mali JWH, Kuiper JP, Hamers AA. Acroangiodermatitis of the foot. Arch Dermatol 1965; 92: 515-8.
200. Rashkovsky I, Gilead L, Schamroth J, Leibovici V. Acro-angiodermatitis: review of the literature and report of a case. Acta Derm Venereol Suppl (Stockh) 1995; 75: 475-8.
201. Stewart WM. Fausse angiosarcomatose de Kaposi par fistules arteriovenulaire multiples. Bull Soc Fr Dermatol Syphil 1967; 74: 664-5.
202. Bluefarb SM, Adams LA. Arteriovenous malformations with angiodermatitis. Arch Dermatol 1967; 96: 176-81.
203. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part I. J Am Ac Dermatol 2007; 56: 353-62.
204. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-20.
205. Gallione CJ, Pasyk KA, Boon LM et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. Med Genet 1995; 32: 197-9.
206. Calvert JT, Riney TJ, Kontos CD et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 1999; 8: 1279-89.
207. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999; 29: 879-93.
208. Pascarella L, Bergan JJ, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg 2005; 19: 457-64.
209. Parkes-Weber F. Angioma formation in connection with hypertrophy of limbs and hemihypertrophy. Br J Dermatol 1907; 19: 231-5.
210. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part II. J Am Acad Dermatol 2007; 56: 541-64.
211. Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay syndrome:a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth. Int J Dermatol 2006; 45: 883-90.
212. Tian X-L, Kadaba R, You S-A et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004; 427: 640-5.
213. Gloviczki P, Stanson AW, Stickler AW et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 1991; 110: 469-79.
214. Lee A, Driscoll D, Gloviczki P et al. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics 2005; 115: 744-9.
215. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg 1995; 82: 757-61.
216. Browse NL, Burnand KG, Irvine AT, Wilson NM, eds. Diseases of the Veins, 2nd edn. London: Arnold,1999.
217. Van Geest AJ, Veraart JC, de Haan M, Neumann HA. Bockenheimer's syndrome. J Eur Acad Dermatol Venereol 1999; 12: 165-8.
218. Weiss T, Madler U, Oberwittler H et al. Peripheral vascular malformation (Servelle-Martorell). Circulation 2000; 101: e82-3.
219. Danarti R, Konig A, Bittar M, Happle R. Inverse Klippel-Trenaunay syndrome:review of cases showing deficient growth. Dermatology 2007; 214: 130-2.
220. Browse NL, Burnand KC, Irvine AT, Wilson NM, eds. Diseases of the Veins, 2nd edn. London: Arnold,1999.
221. Tibbs D. Varicose Veins and Related Disorders. Oxford: Butterworth-Heinemann,1992.
222. Gillot C. Anatomical Atlas of the Lower Limb Superficial Venous Network. St Gallen:Ganzoni & Cie AG,2004.
223. Braverman IM, Keh-Yen A. Ultrastructure of the human dermal microcirculation. IV. Valve-containing collecting veins at the dermal-subcutaneous junction. J Invest Dermatol 1983; 81: 438-42.
224. Chant ADB, Jones HO, Townsend JCF et al. Radiological demonstration of the relationship between calf varices and saphenofemoral incompetence. Clin Radiol 1972; 23: 519-23.
225. Caggiati A, Bergan JJ, Glovicki P et al. Nomenclature of the veins of the lower limb: extensions, refinements and clinical application. J Vasc Surg 2005; 41: 19-24.
226. Weiss MA, Weiss RA, Feied CF, eds. Vein Diagnosis and Treatment: A Comprehensive Approach. New York: McGraw-Hill Professional Publishing,2001.
227. Browse NL, Burnand KG, Lea Thomas M. Physiology and functional anatomy. In: Browse NL, Burnand KG, Lea Thomas M, eds. Diseases of the Veins. Pathology, Diagnosis and Treatment. London: Edward Arnold, 1988; 53-69.
228. Summer DS, Zierler RE. Vascular physiology: Essential hemodynamic principles. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: Elsevier Saunders,2005.
229. Reček Č. The venous reflux. Angiology 2004; 55: 541-8.
230. Sarin S, Scurr JH, Coleridge Smith PD. Assessment of stripping the long saphenous vein in the treatment of primary varicose veins. Br J Surg 1992; 79: 889-93.
231. Reček Č. Conception of the venous hemodynamics in the lower extremity. Angiology 2006; 57: 556-63.
232. Summer DS, Zierler RE. Vascular physiology: essential hemodynamic principles. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: Elsevier Saunders, 2005:75-123.
233. Mendes RR, Marston WA. Physiologic assessment of the venous system. In:Rutherford RB, ed. Vascular Surgery. Philadelphia: Elsevier Saunders,2005.
234. Jünger M, Hahn M, Klyscz T, Sterus A. Role of microangiopathy in the development of venous leg ulcers. Prog Appl Microcirc 1999; 23: 180-3.
235. Homans J. The etiology and treatment of varicose ulcer of the leg. Surg Gynecol Obstet 1917; 24: 300-11.
236. De Takats G, Quint H, Tillotsen BI, Crittenden PJ. The impairment of the circulation in the varicose extremity. Arch Surg 1929; 18: 671-86.
237. Blalock A. Oxygen content of blood in patients with varicose veins. Arch Surg 1929; 19: 898-905.
238. Fagrell B. Local microcirculation in chronic venous incompetence and leg ulcers. Vasc Surg 1979; 13: 217-25.
239. McEwan AJ, McArdle CS. Effect of hydroxyethylrutosides on blood oxygen levels and venous insufficiency symptoms in varicose veins. BMJ 1971; 2: 138-41.
240. Piulachs P, Vidal-Barraquer F. Pathogenic study of varicose veins. Angiology 1953; 4: 39.
241. Haimovici H. Abnormal arteriovenous shunts associated with chronic venous insufficiency. J Cardiovasc Surg 1976; 17: 473-82.
242. Michiels C, Arnould T, Thibaut-Vercruyssen R et al. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997; 16: 134-41.
243. Neumann HAM, van Leeuwen M, van den Broek MJTB, Berretty PJM. Transcutaneous oxygen tension in chronic venous insufficiency syndrome. VASA 1984; 13: 213-9.
244. Clyne CAC, Ramsden WH, Chant ADB, Webster JH. Oxygen tension of the skin of the gaiter area of limbs with venous disease. Br J Surg 1985; 72: 644-7.
245. Stacey MC, Burnand KG, Layer GT, Pattison M. Transcutaneous oxygen tensions in assessing the treatment of venous ulcers. Br J Surg 1990; 97: 1050-4.
246. Leu AJ, Yanar A, Pfister G et al. Mikroangiopathie bei chronischer venösen Insuffizienz. Dtsch Med Wschr 1991; 116: 447-53.
247. Bollinger A, Jäger K, Geser A et al. Transcapillary and interstitial diffusion of NA-fluorescein in chronic venous insufficiency with atrophy. Int J Microcirc Clin Exp 1982; 1: 5-17.
248. Huch A, Franzeck UK, Huch R, Bollinger A. A transparent transcutaneous electrode for simultaneous studies of skin capillary morphology, flow dynamics and oxygenation. Int J Microcirc Clin Exp 1983; 2: 103-8.
249. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcerbearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BJM 1982; 285: 1071-7.
250. Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982; 2: 243-5.
251. Neumann HAM, van den Broek MJTB. Increased collagen IV layer in the basal membrane area of the capillaries in severe chronic venous insufficiency. VASA 1991; 20: 26-9.
252. Michel CC. Oxygen diffusion in edematous tissue and through pericapillary cuffs. Phlebology 1990; 5: 223-30.
253. Neumann HAM, van den Broek MJTB, Boersma IH, Veraart JCJM. Transcutaneous oxygen tension in patients with and without pericapillary fibrin cuffs in chronic venous insufficiency, porphyria cutanea tarda and non-venous leg ulcers. VASA 1996; 25: 127-33.
254. Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in the dependent legs of patients with venous hypertension. A possible mechanism for trophic changes in the skin. BJM 1988; 296: 1693-5.
255. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration:a new hypothesis. BJM 1988; 296: 1726-7.
256. Veraart JCJM, Verhaegh MEJM, Neumann HAM et al. Adhesion molecule expression in venous leg ulcers. VASA 1993; 22: 213-8.
257. Peschen M, Lahaye T, Hennig B et al. Expression of the adhesion of molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency with and without atrophie blanche. In:Maessen-Visch MB. Atrophie Blanche (Thesis). Nijmegen: Drukkerij Hendrix Volharding, 1999: 77-87.
258. Falanga V, Eaglestein WH. The 'trap' hypothesis of venous ulceration. Lancet 1993; 341: 1006-8.
259. Neumann HAM, Tazelaar DJ. Compression therapy. In: Bergan JJ, Goldman MP, eds. Varicose Veins and Telangiectasias, Diagnosis and Treatment. St. Louis: Quality Medical Publishing Inc., 1993: 103-22.
260. Neumann HAM. Measurement of microcirculation. In: Altmeyer P. et al., eds. Wound Healing and Skin Physiology. Berlin/Heidelberg: Springer Verlag, 1995:115-26.
261. Neumann HAM, van den Broek MJTB. Increased collagen IV layer in the basal membrane area of the capillaries in severe chronic venous insuficiency. VASA 1991; 20: 20-9.
262. Leu HJ. The prognostic significance of cutaneous and microvascular changes in venous leg ulcers. Vasc Dis 1965; 2: 77-80.
263. Roztocil K, Prerovsky I, Olivia I. The effect of hydroxy-ethylrutosides on capillary filtration rate in the lower limb of man. Eur J Clin Pharmacol 1997; 11: 435-8.
264. Neumann HAM, van den Broek MJTB, Boersma IH, Veraart JCJM. Transcutaneous oxygen tension in patients with and without pericapillary fibrin cuffs in chronic venous insufficiency, porphyria cutanea tarda and non-venous leg ulcers. VASA 1996; 25: 127-33.
265. Fagrell B. Microcirculatory disturbances-the final cause for leg ulcers? VASA 1982; 11: 101-3.
266. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcerbearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BJM 1982; 285: 1071-7.
267. Herouy Y, May AE, Pornschlegel G et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol 1998; 111: 822-7.
268. Jarrett PE, Burnand KG, Morland M, Browse NL. Fibrinolysis and fat necrosis in the lower leg. Br J Surg 1976; 63: 157.
269. Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HAM. Atrophie blanche, a review. Int J Dermatol 1999; 38: 161-72.
270. Nordstrøm M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-60.
271. Kyrle PA. Deep vein thrombosis. Lancet 2005; 365: 1163-74.
272. McRae S, Tran H, Schulman S et al. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 2006; 368: 371-8.
273. Browse NL, Burnand KC, Irvine AT, Wilson NM, eds. Disease of the Veins, 2nd edn. London: Arnold,1999.
274. Boey ML, Colaco CB, Chavari AE et al. Thrombosis in systemic lupus erythematosus:striking association with the presence of circulating antcoagulants. BMJ 1983; 287: 289.
275. Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus coagulant. Ann Intern Med 1980; 92: 156-9.
276. Dahlback B. Physiological anticoagulation. J Clin Invest 1994; 94: 923.
277. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44: 62-9.
278. Stein PD, Hull RD, Patel KC et al. d-Dimer for the exclusion of acute venous thromboembolism and pulmonary embolism. Ann Intern Med 2004; 140: 589-602.
279. Michiels JJ, Gadisseur A, van der Planken M et al. A critical appraisal of noninvasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism:how many tests do we need? Int Angiol 2005; 24: 27-39.
280. Michiels JJ, Gadisseur A, van der Planken M et al. Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools. Semin Vasc Med 2005; 5: 351-64.
281. Segal JB, Streiff MB, Hofmann LV et al. Management of venous thromboembolism:a systematic review for a practice guideline. Ann Intern Med 2007; 146: 211-22.
282. Pini M, Spyropoulos AC. Prevention of venous thromboemolism. Semin Thromb Hemost 2006; 32: 755-66.
283. Blann AD, Lip GYH. Venous thromboembolism. BMJ 2006; 332: 215-9.
284. Wentel TD, Neumann HAM. Management of the postthrombotic syndrome: the Rotterdam approach. Semin Thromb Hemost 2006; 32: 814-21.
285. Marchiori A, Mosena L, Prandoni P. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Semin Thromb Hemost 2006; 32: 737-43.
286. Wichers IM, Di Nisio M, Büller HR, Middelkoop S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 2005; 90: 672-7.
287. Di Nisio M, Wichers IM, Middelkoop S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007; 18: CD004982.
288. Leon L, Giannoukas AD, Dodd D et al. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005; 29: 10-7.
289. Decousus H, Epinat M, Guillot K et al. Superficial venous thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med 2003; 9: 393-7.
290. Cruikshrank AH. Venous thrombosis in the internal organs associated with thrombosis of the leg veins. J Pathol Bacteriol 1956; 71: 383-6.
291. Lieberman JS, Borrero J, Urdanetta E et al. Thromboembolism associated with neoplasm: review of 77 cases. Circulation 1960; 22: 780.
292. Samlaska CP, James WD. Superficial thrombophlebitis. I. Primary hypercoagulable states. J Am Acad Dermatol 1990; 22: 974-89.
293. Samlaska CP, James WD. Superficial thrombophlebitis. II. Secondary hypercoagulable states. J Am Acad Dermatol 1990; 23: 1-18.
294. Bollinger A, Leu HJ. Thrombophlebitis saltans. Deutsch Med Wochenschr 1974; 99: 1433-6.
295. Forman L. Thrombophlebitis and arteritis in the pathology of Behçet's syndrome. Hautarzt 1960; 11: 363-6.
296. Fazeli B, Modaghegh H, Ravrai H, Kazemzadeh G. Thrombophlebitis migrans as a footprint of Buerger's disease: a prospective-descriptive study in north-east of Iran. Clin Rheumatol 2008; 27: 55-7
297. Sack C, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic and therapeutic features. Medicine 1977; 56: 1-37.
298. Samlaska CP, Jones WD, Simel DL. Superficial migratory thrombophlebitis and factor XII deficiency. J Am Acad Dermatol 1990; 22: 939-43.
299. Nordstrom M, Lindblad B, Anderson H et al. Deep vein thrombosis and occult malignancy: epidemiological study. BMJ 1994; 308: 891-4.
300. Chajek T, Fainaru M. Behçet's disease with decreased fibrinolysis and superior vena cava occlusion. BMJ 1973; 1: 782.
301. Cunliffe WJ, Roberts BE, Dodman B. Behçet's disease syndrome and oral fibrinolytic therapy. BMJ 1973; 2: 486-7.
302. Graham-Brown RAC, Sarkany I. Failure of colchicine and fibrinolytic therapy in Behçet's disease. Clin Exp Dermatol 1980; 5: 87-92.
303. Mondor H. Tronculite sous-cutanee subaigue de la paroi thoracigue antero-laterale. Mem Acad Chir 1939; 65: 1271-8.
304. De Godoy JM, Godoy MF, Batigália F, Braile DM. The association of Mondor's disease with protein S deficiency: case report and review of literature. J Thromb Thrombolysis 2002; 93: 187-9.
305. Al-Mwalad M, Loertzer H, Wicht A, Fornara P. Subcutaneous penile vein thrombosis (penile Mondor's disease): pathogenesis, diagnosis, and therapy. Urology 2006; 67: 586-8.
306. Catania S, Zurrida S, Veronesi P et al. Mondor's disease and breast cancer. Cancer 1992; 69: 2267-70.
307. Moskovitz AH, Anderson BO, Yeung RS et al. Axillary web syndrome after axillary dissection. Am J Surg 2001; 181: 434-9.
308. Leidenius M, Leppänen E, Krogerus L, von Smitten K. Motion restriction and axillary web syndrome after sentinal node biopsy and axillary clearance in breast cancer. Am J Surg 2003; 185: 127-30.
309. Craythorne EE, Roberts J, Higgins EM, Macfarlane CS. 'Axillary web syndrome' or 'cording': an unusual postsurgical complication and localized variant of Mondor's disease. Br J Dermatol 2008; 159 (Suppl. 1): 109.
310. Browse NL, Burnand KG, Irvine NM. Disease of the Veins, 2nd edn. London:Arnold, 1999: 409-25.
311. Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg 1965; 52: 816-21.
312. Widmer LK, Plechl SC, Leu HJ et al. Venenkrankungen bei 1800 Berufstätigen. Basel Studie II. Schweiz Med Wochensch 1967; 97: 107-10.
313. Porter JM, Moneta GL. Reporting standard in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21: 635-45.
314. Eklof B, Rutherford RB, Bergan J et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40: 1248-52.
315. Rutherford RB, Padberg FT Jr, Comerota AJ et al. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000; 31: 1307-12.
316. Mellor RH, Brice G, Stanton AW et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007; 115: 1912-20.
317. Malten LE, Kuiper JP, van der Staak WBJM. Contact allergic investigations in 100 patients with ulcus cruris. Dermatologica 1973; 147: 241-5.
318. Perrenoud D, Ramelet AA. Chronic leg ulcers and eczema. Curr Probl Dermatol 1999; 27: 165-9.
319. Bhushan M, Cox NH, Chalmers R. Eczema craquele due to oedema. Br J Dermatol 2001; 145: 355-7.
320. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcerbearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BMJ 1982; 285: 1071-7.
321. Maessen-Visch MB, Koedam MI, Hamulyak K, Neumann HAM. Atrophie blanche, a review. Int J Dermatol 1999; 38: 161-72.
322. Janssen MC, Haenen JH, Asten WN et al. Clinical and haemodynamic sequelae of deep venous thrombosis: retrospective evaluation after 7-13 years. Clin Sci 1997; 93: 7-12.
323. Coleridge-Smith P, Labropoulos N, Partsch H et al. Duplex ultrasound investigation of veins in chronic venous disease of the lower limbs-UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 2006; 31: 83-92.
324. Lagatolla NR, Donald A, Lockhart S, Burnand K. Retrograde flow in the deep veins of subjects with normal venous function. Br J Surg 1997; 84: 36-9.
325. van Bemmelen PS, Mattos MA, Hogdson KJ et al. Does air plethysmography correlate with duplex scanning in patients with chronic venous insufficiency? J Vasc Surg 1993; 18: 796-807.
326. Ricci S, Georgiev M. Ultrasound anatomy of the superficial veins of the lower limb. J Vasc Technol 2002; 26: 183-99.
327. Beecher HK, Field ME, Krogh A. Effect of walking on venous pressure at the ankle. Skand Arch Physiol 1936; 73: 133-9.
328. Barber RF, Shatara FI. The varicose disease. NY State J Med 1925; 31: 574-80.
329. Pollack AA, Wood EH. Venous pressure in the saphenous vein in ankle in men during exercise and changes in posture. J Appl Physiol 1949; 1: 649-53.
330. Arnoldi CC. Venous pressure: the function of the venous pump in chronic venous insufficiency. J Cardiovasc Surg (Torino) 1961; 2: 116-27.
331. Kuiper JP. Venous pressure determination (direct method). Dermatologica 1966; 132: 206-17.
332. Brodie TG, Russel AE. On the determination of the rate of blood flow through an organ. J Physiol 1905; 32: 47.
333. Hertzman AB. The blood supply of various skin areas as estimated by the photoelectric plethysmography. Am J Physiol 1938; 124: 328-40.
334. Abramowitz HB, Queral LA, Flinn WR. The use of photoplethysmography in the assessment of venous insufficiency. A comparison to venous pressure measurements. Surgery 1979; 86: 434-41.
335. Wienert V, Blazek V. New method for non-invasive measurement of venous pressure. Hautarzt 1982; 33: 498-9.
336. Bays RA, Healy DA, Atnip RG, Neumyer M, Thiele BL. Validation of air plethysmography, photoplethysmography, and duplex ultrasonography in the evaluation of severe venous stasis. J Vasc Surg 1994; 20: 721-7.
337. Wienert V, Blazek V. Eine neue Methode zur unblutigen dynamischen Venendruckmessung. Hautarzt 1982; 33: 498-9.
338. Blazek V, Schmitt HJ, Schultz-Ehrenberg U. Digitale Photoplethysmographie: Ein neues mikroprozessorgesteuertes Messsystem für die Beinvenendiagnostiek. Biomed Tch 1988; 33: 307-8.
339. Kerner J, Schultz-Ehrenberg U, Blazek V. Digitale Photoplethysmographie (DPPG)-klinische Eignung der neuen Messmethode zur venosen Funktionsdiagnostik. Phlebol Proktol 1989; 18: 98-103.
340. Veraart JCJM, van der Kley AMJ, Neumann HAM. Digital photoplethysmography and light reflection rheography. J Dermatol Surg Oncol 1994; 20: 470-3.
341. O'Donnell TF, McEnroe CS, Heggerick P. Chronic venous insufficiency. Surg Clin North Am 1990; 70: 159-80.
342. Lea Thomas M, ed. Phlebography of the Lower Limbs. New York: Churchill Livingstone,1982.
343. Krijnen RMA, de Boer EM, Bruyunzeel DP. Epidemiology of venous disorders in the general and occupational population. Epidemiol Rev 1997; 19: 294-309.
344. Rabe E, Pannier-Fischer F, Bromen K et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie-epidemiologische Untersuchung zur Frage der Häufigkeit und Aussprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003; 32: 1-14.
345. Mellor RH, Brice G, Stanton AW et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007; 115: 1912-20.
346. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007; 26: 22-8.
347. van den Bos R, Arends L, Kockaert M et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009; 49: 230-9.
348. Iafrati MD. Subfascial endoscopic perforator vein surgery. Semin Cutan Med Surg 2005; 24: 209-15.
349. De Roos KP, Nieman FHM, Neumann HAM. Ambulatory phlebectomy versus compression sclerotherapy: results of a randomized controlled trial. Dermatol Surg 2003; 29: 221-6.
350. van den Bos RR, Kockaert MA, Neumann HAM, Nijsten T. Technical review of endovenous laser therapy for varicose veins. Eur J Vasc Endovasc Surg 2008; 35: 88-95.
351. Mussa FF, Peden EK, Zhou W, Lin PH et al. Iliac vein stenting for chronic venous insufficiency. Tex Heart Inst J 2007; 34: 60-6.
352. Apfelberg DB, Smith T, Maser MR. Study of three laser systems for treatment of superficial varicosities of the lower extremity. Lasers Surg Med 1987; 7: 219-23.
353. Neumann HAM. Compression therapy with medical elastic compression stockings for venous diseases. Dermatol Surg 1998; 24: 765-70.
354. Comité European de Normalisation, adopted European prestandard. Medical Compression Hosiery. ENV 12718. Brussels: Comité Européen de Normalisation,2001.
355. Veraart JC, Daamen E, de Vet HC et al. Elastic compression stockings: durability of pressure in daily practice. Vasa 1997; 26: 282-6.
356. Anderson JA et al. Paroven and graduated compression hosiery for superficial venous insufficiency. Phlebology 1990; 5: 271-6.
357. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effects of elastic stockings in patients with varicose veins. Int Angiol 1994; 13: 119-23.
358. Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly 2001; 131: 659-62.
359. Zimmet SE. Sclerotherapy treatment of telangiectasias and varicose veins. Tech Vasc Interv Radiol 2003; 6: 116-20.
360. Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev 2006; 4: CD001732.
361. Neumann HAM. Compression therapy with medical elastic compression stockings for venous diseases. Dermatol Surg 1998; 24: 765-70.
362. Comité European de Normalisation, adopted European prestandard. Medical Compression Hosiery. ENV 12718. Brussels: Comité Européen de Normalisation,2001.
363. Veraart JC, Daamen E, de Vet HC et al. Elastic compression stockings: durability of pressure in daily practice. Vasa 1997; 26: 282-6.
364. Anderson JA et al. Paroven and graduated compression hosiery for superficial venous insufficiency. Phlebology 1990; 5: 271-6.
365. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effects of elastic stockings in patients with varicose veins. Int Angiol 1994; 13: 119-23.
366. Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly 2001; 131: 659-62.
367. Keller WL. A new method of extirpating the internal saphenous and similar veins in varicose conditions: a preliminary report. NY Med J 1905; 82: 385-6.
368. Ceulen RPM, Kessels A, Veraart JCJM, van Neer PAFA. Lateral venous ulceration and incompetence of the small saphenous vein. Dermatol Surg 2007; 33: 727-30.
369. van den Bos R, Arends L, Kockaert M et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009; 49: 230-9.
370. De Maeseneer MG, Van Schil PE, Philippe MM et al. Is recurrence of varicose veins after surgery unavoidable? Acta Chir Belg 1995; 95: 21-6.
371. Kalra M, Gloviczki P. Subfascial endoscopic perforator vein surgery: who benefits? Semin Vasc Surg 2002; 15: 39-49.
372. Hauer G. The endoscopic subfascial division of the perforating veins-preliminary report. Vasa 1985; 14: 59-61.
373. Van Gent WB, Hop WC, Van Praag MC et al. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial. J Vasc Surg 2006; 44: 563-71.
374. Muller R. Traitement des varices par la phlébectomie ambulatoire. Phlébologie 1966; 19: 277-9.
375. De Roos KP, Nieman FH, Neumann HAM. Ambulatory phlebectomy versus compression sclerotherapy: results of a randomized controlled trial. Dermatol Surg 2003; 29: 221-6.
376. van den Bos R, Arends L, Kockaert M et al. Endovenous therapies of lower extremity varicosities: a meta-analysis and meta-regression of case series and randomized clinical trials. J Vasc Surg 2009; 49: 230-9.
377. van den Bos RR, Kockaert MA, Neumann HAM, Nijsten T. Technical review of endovenous laser therapy for varicose veins. Eur J Vasc Endovasc Surg 2008; 35: 88-95.
378. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
379. O'Hare JL, Earnshaw JJ. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg 2007; 34: 232-5.
380. Neglén P, Berry MA, Raju S. Endovascular surgery in the treatment of chronic primary and post-thrombotic iliac vein obstruction. Eur J Vasc Endovasc Surg 2000; 20: 560-71.
381. Neglén P, Raju S. Proximal lower extremity chronic venous outflow obstruction:recognition and treatment. J Vasc Surg 2002; 15: 57-64.
382. Schroeter CA, Wilder D, Reineke T et al. Clinical significance of an Intense Pulsed Light Source on leg telangiectasias of up to 1 mm diameter. Eur J Dermatol 1997; 7: 38-42.
383. Sadick NS. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins. J Am Acad Dermatol 2002; 46: 66-72.
384. Fodor L, Ramon Y, Fodor A et al. A side-by-side prospective study of intense pulsed light and Nd: YAG laser treatment for vascular lesions. Ann Plast Surg 2006; 56: 164-70.
385. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2005; CD003229.
386. Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patients multicentre study in the UK. Vasa 1983; 12: 373-6.
387. Wentel TD, Neumann HAM. Management of the postthrombotic syndrome: the Rotterdam approach. Semin Thromb Hemost 2006; 32: 814-21.
388. Kolbach DN, Sandbrink MWC, Neumann HAM, Prins MH. Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome. Cochrane Database Syst Rev 2003; 4: CD004177.
389. Kolbach DN, Sandbrink MWC, Hamulyak K et al. Non-pharmaceutical management for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2004; 1: CD004174.
390. Kahn SR. The post-thrombotic syndrome: The forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis 2006; 21: 41-8.
391. Neumann HAM, Veraart JCJM. Morphological and functional skin changes in postthrombotic syndrome. Wien Med Wschr 1994; 144: 204-6.
392. Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134: 357-65.
393. Villalta S, Bagatella P, Piccioli A et al. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis 1994; 24 (Suppl. 1): 57a (abstract).
394. Kolbach DN, Neumann HAM, Prins MH. Definition of the post-thrombotic syndrome, differences between existing classifications. Eur J Vasc Endovasc Surg 2005; 30: 404-14.
395. Prandoni P, Lensing AWA, Prins MH et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome. A randomized controlled trial. Ann Intern Med 2004; 141: 249-56.
396. Neglén P, Raju S. Proximal lower extremity chronic venous outflow obstruction:recognition and treatment. Semin Vasc Surg 2002; 15: 57-64.
397. Palma EC, Esperon R. Vein transplants and grafts in the surgical treatment of the postphlebitic syndrome. J Cardiovasc Surg 1960; 1: 94-107.
398. Basmajian JW. The distribution of valves in the femoral, external iliac and common iliac vein and their relationship to varicose veins. Surg Gynec Obstet 1952; 95: 537.
399. Kistner RL. Surgical repair of the incompetent femoral vein valve. Arch Surg 1975; 110: 1336.
400. Mellor RH, Brice G, Stanton AW et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007; 115: 1912-20.
401. Reichenberg J, Davis M. Venous ulcers. Semin Cutan Surg 2005; 24: 216-61.
402. Ruckley CV. Caring for patients with chronic leg ulcer. BMJ 1998; 3316: 407-8.
403. Valencia IC, Falabella A, Kirsner RS et al. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44: 401-21.
404. Bergan JJ, Schmid-Schonbein GW, Coleridge Smith PD et al. Mechanisms of disease: chronic venous disease. N Eng J Med 2006; 355: 288-98.
405. Cornwall JV, Dore CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986; 73: 693-6.
406. Callum MJ, Ruckley CV, Harper DR et al. Chronic ulceration of the leg: extent of the problem and provision of care. BMJ 1985; 290: 1855-6.
407. Nelzen O, Bergquist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg 1994; 81: 182-7.
408. Schulz EJ, Findlay GH, Scott FP. Skin disease in the Bantu: a survey of 4000 cases from the Transvaal and Orange Free State. S Afr Med J 1962; 36: 199-202.
409. Shrank AB, Harman RRM. The incidence of skin disease in a Nigerian teaching hospital dermatological clinic. Br J Dermatol 1966; 78: 235-41.
410. Doglietti M. Skin disorders in the Bantu: a survey of 2000 cases from Baragwanath Hospital. S Afr Med J 1970; 44: 670-2.
411. Borschberg E, ed. The Prevalence of Varicose Veins of the Lower Extremities. Basle:Karger,1967.
412. Anning ST, ed. Leg Ulcers: Their Causes and Treatment. London: Churchill,1954.
413. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997; 48: 67-9.
414. Hjelmstedt A, Bergvall U. Incidence of thrombosis in patients with tibial fractures. Acta Chir Scand 1967; 134: 1-10.
415. Munkvad S, Jørgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1996; 134: 296-8.
416. Maessen-Visch MB, Hamulyak K, Tazelaar DJ et al. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 1999; 135: 41-4.
417. Mackenzie RK, Ludlam CA, Ruckley CV et al. The prevalence of thrombophilia in patients with chronic venous ulceration. J Vasc Surg 2002; 35: 718-22.
418. Zollner TM, Veraart JC, Wolter M et al. Leg ulcers in Klinefelter's syndrome-further evidence for an involvement of plasminogen activator inhibitor-1. Br J Dermatol 1997; 136: 341-4.
419. Scriven JM, Hartshorne T, Bell PRF et al. Single visit venous ulcer assessment clinic: the first year. Br J Surg 1997; 84: 334-6.
420. Lodin A, Lindvall N, Gentele H. Congenital absence of venous valves as a cause of leg ulcers. Acta Chir Scand 1959; 116: 256-70.
421. Ryan TJ. The epidermis and its blood supply in venous disorders of the leg. Trans St John's Hosp Dermatol Soc 1969; 55: 51-65.
422. Grey JE, Enoch S, Harding KG. Venous and arterial leg ulceration. BMJ 2006; 52: 593-603.
423. Browse NL, Burnand K, Irvine AT, Wilson NM. Diseases of the Veins, 2nd edn. London: Arnold,1999.
424. Ryan TJ, ed. Management of Leg Ulcers. Oxford: Oxford University Press,1987.
425. Stevens AE, Ball KP. General disease among leg ulcer patients. Trans St John's Hosp Dermatol Soc 1964; 50: 43-7.
426. Sugerman HJ. Effects of increased abdominal pressure in severe obesity. Surg Clin North Am 2001; 81: 1063-75.
427. Koshy M, Entsuah R, Koranda A et al. Leg ulcers in patients with sickle cell disease. Blood 1989; 74: 1403-8.
428. Wilkinson DS. Nursing and Management of Skin Diseases, 4th edn. London: Faber and Faber,1977.
429. Greaves M, Boyde TRC. Plasma-zinc concentrations in patients with psoriasis, other dermatoses and venous leg ulceration. Lancet 1967; ii: 1019-20.
430. Greaves MW, Ive FA. Double-blind trial of zinc sulphate in the treatment of chronic venous leg ulceration. Br J Dermatol 1972; 87: 632-4.
431. Greaves MW, Skillen AW. Effects of long-continued ingestion of zinc sulphate in patients with venous leg ulceration. Lancet 1970; ii: 889-91.
432. Myers MB, Cherry G. Zinc and the healing of chronic leg ulcers. Am J Surg 1970; 120: 77-81.
433. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. Lancet 1970; ii: 891-2.
434. Pories WJ, Henzel JH, Rob CG et al. Acceleration of wound healing in man with zinc sulphate given by mouth. Lancet 1967; i: 121-4.
435. Hallböök T, Lanner E. Serum-zinc and healing of venous ulcers. Lancet 1972; ii:780-2.
436. Husain SL. Oral zinc sulphate in leg ulcers. Lancet 1969; i: 1069-71.
437. Wilkinson EA, Hawke CI. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev 2000; CD001273.
438. Kontiainen S, Rinne E. Bacteria in ulcera crurum. Acta Derm Venereol (Stockh) 1988; 68: 240-4.
439. Alinovi A, Bassini P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. J Am Acad Dermatol 1986; 15: 186-91.
440. Phillips TJ, Dover JS. Leg ulcers. J Am Acad Dermatol 1991; 25: 965-89.
441. Rodehaver G. Controversies in topical wound management. Wounds 1989; 1: 19-27.
442. Lookingbill DP, Miller SH, Knowles RC. Bacteriology of chronic leg ulcers. Arch Dermatol 1978; 114: 1765-8.
443. Bull RH, Mortimer PS. Erosive pustular dermatosis of the leg. Br J Dermatol 1995; 132: 279-82.
444. English MP, Smith RJ, Harman RRM. The fungal flora of ulcerated legs. Br J Dermatol 1971; 84: 567-81.
445. Hanson C, Faergemann J, Swanbeck E. Fungal infections occurring under bandages in leg ulcer patients. Acta Derm Venereol (Stockh) 1987; 67: 341-5.
446. Mertz PM, Eaglstein WH. The effect of occlusive dressing on the microbial population in superficial wounds. Arch Surg 1984; 119: 287-9.
447. Mitchell AAB, Pettigrew JB, MacGillvray D. Varicose ulcers as reservoirs of hospital strains of Staph. aureus and Pseudomonas pyocyanea. Br J Clin Pract 1970; 24: 223-6.
448. Schmidt K, Debus ES, Jessberger ST et al. Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous and the arterial ulcer? Vasa 2000; 29: 62-70.
449. Tavadia S, Bianchi J, Dawe RS et al. Allergic contact dermatitis in venous leg ulcer patients. Contact Dermatitis 2003; 48: 261-5.
450. Angelini G, Rantuccio F, Meneghini CL. Contact dermatitis in patients with leg ulcers. Contact Dermatitis 1975; 1: 81-7.
451. Kulozik M, Powell S, Cherry GW et al. Contact sensitivity in community-based leg ulcers. Clin Exp Dermatol 1988; 13: 82-4.
452. Wilson CL, Cameron J, Powell SM et al. High incidence of contact dermatitis in leg ulcer patients: implications for management. Clin Exp Dermatol 1991; 16: 250-3.
453. Hardie RA, Benton EC, Hunter JAA. Adverse reactions to paste bandages. Clin Exp Dermatol 1982; 7: 135-42.
454. Jankićević J, Vesić S, Vukićević J et al. Contact sensitivity in patients with venous leg ulcers in Serbia: comparison with contact dermatitis patients and relationship to ulcer duration. Contact Dermatitis 2008; 58: 32-6.
455. Harman RRM. Haemorrhage from varicose veins. Lancet 1974; i: 363.
456. Evans CA, Evans DMD, Seal RME et al. Spontaneous fatal haemorrhage caused by varicose veins. Lancet 1973; ii: 1359-61.
457. Dupuy A, Benchikhi H, Roujeau JC et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999; 318: 1591-4.
458. Pennel TC, Hightower F. Malignant changes in post-phlebitic ulcers. South Med J 1965; 58: 779-81.
459. Baldursson BT, Hedblad MA, Beitner H et al. Squamous cell carcinoma complicating chronic venous leg ulceration: a study of the histopathology, course and survival in 25 patients. Br J Dermatol 1999; 140: 1148-52.
460. Lagattolla NRF, Burnand KG. Chronic venous disease may delay the diagnosis of malignant ulceration of the leg. Phlebology 1994; 9: 167-9.
461. Cox NH, Long ED. Pseudoangiosarcomatous squamous cell carcinoma of skin. Histopathology 1993; 22: 295-6.
462. Sarkany I, Kreel L. Subcutaneous ossification of the legs in chronic venous statis. BMJ 1966; ii: 27-8.
463. Lippman HI, Goldin RR. Subcutaneous ossification of the legs in chronic venous insufficiency. Radiology 1960; 74: 279-81.
464. Grabs AJ, Wakely MC, Nyamekye I et al. Colour duplex ultrasonography in the rational management of chronic venous leg ulcers. Br J Surg 1996; 83: 1380-2.
465. Reichenberg J, Davis M. Venous ulcers. Semin Cutan Med Surg 2005; 24: 216-26.
466. Lagattolla NRF, Burnard KG. Chronic venous disease may delay the diagnosis of malignant ulceration of the leg. Phlebology 1994; 9: 167-9.
467. Browse NL, Burnand KG, Irvine AT, Wilson NM. Diseases of the Veins, 2nd edn. London: Arnold,1999.
468. Ryan TJ, ed. The Management of Leg Ulcers, 2nd edn. Oxford: Oxford University Press,1987.
469. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent and provision of care. BMJ 1985; 290: 1855-6.
470. Freak L, Simon D, Kinsella A et al. Leg ulcer care: an audit of cost effectiveness. Health Trends 1995; 27: 133-6.
471. Mathus-Vliegen EM. Old age, malnutrition and pressure sores; an ill-fated alliance. J Gerontol A Biol Sci Med Sci 2004; 59: 355-60.
472. Freiman A, Bird G, Metelitsa AL et al. Cutaneous effects of smoking. J Cutan Med Surg 2004; 8: 415-23.
473. Benveniste K, Thut P. The effect of chronic alcoholism on wound healing. Proc Soc Exp Biol Med 1981; 166: 568-75.
474. Hess CT, Trent JT. Incorporating laboratory values in chronic wound management. Adv Skin Wound Care 2004; 17: 378-86.
475. Etufugh CN, Philips TJ. Venous ulcers. Clin Dermatol 2007; 25: 121-30.
476. Fletcher A, Cullum N, Sheldon TA. A systematic review of compression treatment for venous leg ulcers. BMJ 1997; 325: 576-80.
477. Cullum N, Fletcher A, Nelson E, Sheldon T. Compression for venous leg ulcers. Cochrane Database Syst Rev 2001; 2: CD000265.
478. Van Gent WB, Hop WC, Van Praag MC et al. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial. J Vasc Surg 2006; 44: 563-71.
479. Morrell CJ, Walters SJ, Dixon S et al. Cost effectiveness of community leg ulcer clinics: randomised controlled trial. BMJ 1998; 316: 1487-91.
480. Thomas S. Bandages and bandaging: the science behind the art. Care Sci Pract 1990; 8: 61-2.
481. Blair SD, Wright DDT, Backhouse CM et al. Sustained compression and healing of chronic venous ulcers. BMJ 1988; 297: 1159-61.
482. Nelson EA, Ruckley CV, Barbenel JC. Improvements in bandaging technique following training. J Wound Care 1995; 4: 181-4.
483. Jünger M, Wollina U, Kohnen R, Rabe E. Efficacy and tolerability of an ulcer compression stocking for the therapy of chronic venous ulcer compared with a below-knee compression bandage: results from a prospective, randomized, multicentre trial. Curr Med Res Opin 2004; 20: 1613-23.
484. Lucaroth ME, Morgan AP, Leaper DT. The effect of antiseptics and the moist wound environment on ulcer healing: an experimental and biochemical study. Phlebology 1990; 5: 173-9.
485. Svedman P. Irrigation treatment of leg ulcers. Lancet 1983; ii: 532-4.
486. Angeras HM, Brandberg A, Falk A, Seeman T. Comparison between sterile saline and tap water for the cleansing of acute soft tissue wounds. Eur J Surg 1992; 158: 347-50.
487. Bradley M, Cullum N, Sheldon T. The debridement of chronic wounds: a systematic review. Health Technol Assess 1999; 3: 1-78.
488. Steed DL. Debridement. Am J Surg 2004; 187: S71-4.
489. Williams D, Enoch S, Miller D et al. Effect of sharp debridement using curette on recalcitrant venous ulcers: a concurrently controlled, prospective cohort study. Wound Rep Reg 2005; 13: 131-7.
490. Konig M, Vanscheidt W, Augustin M et al. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomized trial. J Wound Care 2005; 14: 320-3
491. Vuerstaek JD, Vainas T, Wuite J et al. State-of-the-art treatment of chronic leg ulcers: a randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg 2006; 44: 1029-37.
492. Sherman RA, Tran JM, Sullivan R. Maggot therapy for venous stasis ulcers. Arch Dermatol 1996; 132: 254-6.
493. Tan J, Abisi S, Smith A, Burnand KG. A painless method of ultrasonically assisted debridement of chronic leg ulcers: a pilot study. Eur J Vasc Endovasc Surg 2007; 33: 234-8.
494. Thomas S. Wound Management and Dressings. London: Pharmaceutical Press,1990.
495. Fonder MA, Lazarus GS, Cowan DA et al. Treating the chronic wound: a practical approach to the care of non-healing wounds and wound care dressings. J Am Acad Dermatol 2008; 58: 185-206.
496. Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007; 335: 244.
497. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 2002; 44: 745-57.
498. Mayer W, Jochmann W, Partsch H. Varicose ulcer: healing in conservative therapy. A prospective study. Wien Med Wochenschr 1994; 144: 250-2.
499. Siegel DM. Contact sensitivity and recalcitrant wounds. Ostomy Wound Manage 2000; 46: S65-74.
500. Falanga V, Margolis D, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol 1998; 134: 293-300.
501. O'Meara S, Al-Kurdi D, Ovington L. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008; 1: CD003557.
502. Skene AI, Smith JM, Dore CJ et al. Venous leg ulcers: a prognostic index to predict time to healing. BMJ 1992; 305: 1119-21.
503. Trengove NJ, Stacey MC, McGechie DF et al. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996; 5: 277-80.
504. Hofman D, Ryan TJ, Arnold F et al. Pain in venous leg ulcers. J Wound Care 1997; 6: 222-4.
505. Hannington-Kiff JG. Pharmacological target blocks in painful dystrophic limbs. In: Wall PD, Melzack R, eds. Textbook of Pain. Edinburgh: Churchill Livingstone, 1989: 754-66.
506. Young JB, Javid M, George J. Rest cramps in the elderly. J R Coll Phys (Lond) 1989; 23: 103-5.
507. Erikssen G, Eklund A, Liden S et al. Comparison of different treatments of venous leg ulcers: a controlled study using stereophotogrammetry. Curr Ther Res 1984; 35: 678-84.
508. Stacey MC, Burnand KG, Layer FT et al. Measurement of the healing of venous ulcers. Aust N Z J Surg 1991; 61: 844-8.
509. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers: a randomized clinical trial. J Am Acad Dermatol 1986; 15: 186-91.
510. Jull A, Arroll B, Parag V, Waters J. Pentoxifylline for treating venous leg ulcer. Cochrane Database Syst Rev 2007; 3: CD001733.
511. Layton AM, Ibbotson SH, Davies JA et al. Randomised trial of oval aspirin for chronic venous leg ulcers. Lancet 1994; 344: 164-5.
512. Guilhou JJ, Dereure O, Marzin L et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double blind randomized controlled versus placebo trial in 107 patients. Angiology 1997; 48: 77-85.
513. Burnand K, Clemenson S, Morland M et al. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression. BMJ 1980; 280: 7-11.
514. Fernandes Abbade LP, Lastoria S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 2005; 44: 449-56.
515. Baldursson B, Sigurgeirsson B, Lindelof B. Venous leg ulcers and squamous cell carcinoma: a large-scale epidemiological study. Br J Dermatol 1995; 133: 571-4.
516. Anon. Compression hosiery for stasis disorders. Drug Ther Bull 1982; 20: 81-4.
517. Thomas S. Bandages and bandaging: the science behind the art. Care Sci Pract 1990; 8: 61-2.
518. Browse NL, Burnand KG, Irvine AT et al., eds. Diseases of the Veins: Pathology, Diagnosis and Treatment, 2nd edn. London: Arnold,1999.
519. Neumann HAM Compression therapy with medical elastic stockings for venous disease. Dermatol Surg 1998; 24: 765-70.
520. Tibbs D. Varicose Veins and Related Disorders, 2nd edn. Oxford: Butterworth-Heinemann,1997.
521. Gohel MS, Barwell JR, Taylor M et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR):randomised controlled trial. BMJ 2007; 335: 83-8.
522. Fegan WG. Varicose Veins and Compression Sclerotherapy. London: Heinemann,1971.
523. Lofgren KA, Lauvstad WA, Bonnemaison MFE. Surgical treatment of large stasis ulcer: review of 129 cases. Mayo Clin Proc 1965; 40: 560-3.
524. Silver D, Gileysteen JJ, Rhodes GR et al. Surgical treatment of refractory postphlebitic ulcer. Arch Surg 1971; 103: 554-60.
525. Padberg FT Jr. Surgical intervention in venous ulceration. Cardiovasc Surg 1999; 7: 83-90.
526. Burnand K, Thomas ML, O'Donnell T et al. Relation between post-phlebitic changes in the deep veins and results of surgical treatment of venous ulcers. Lancet 1976; i: 936-8.
527. Anon. Compression hosiery for stasis disorders. Drug Ther Bull 1982; 20: 81-4.
528. Schmeller W, Gaber Y, Gehl HB. Shave therapy is a simple effective treatment of persistent venous ulcers. J Am Acad Dermatol 1998; 39: 232-8.
529. Abisi S, Tan J, Burnand KG. Excision and meshed skin grafting for leg ulcers resistant to compression therapy. Br J Surg 2007; 94: 194-7
530. Dahl MGC. Skin grafting on the lower leg as an outpatient ambulatory procedure. Br J Dermatol 1985; 113 (Suppl. 29): 14.
531. Harrison PV. Split skin grafting of varicose leg ulcers: a survey and the importance of assessment of risk factors in predicting outcome from the procedure. Clin Exp Dermatol 1987; 13: 4-6.
532. Phillips TJ, Bhawan J, Leigh IM et al. Cultured epidermal autografts and allografts: a study of differentiation and allograft survival. J Am Acad Dermatol 1990; 23: 189-98.
533. Nanninga PB, Mekkes JR, De Vries HJC et al. Grafting techniques. In: Westerhoff W, ed. Leg Ulcers: Diagnosis and Management. Amsterdam: Elsevier, 1993:335-55.
534. Welch HJ. Surgical options for the treatment of venous ulcers. Vasc Endovasc Surg 2004; 38: 195-202.
535. Van Gent WB, Hop WC, Van Praag et al. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicentre trial. J Vasc Surg 2006; 44: 563-71.
536. Callam MJ, Harper DR, Dale JJ et al. Arterial disease in chronic leg ulceration: an underestimated hazard? Lothian and Forth Valley leg ulcer study. BMJ 1987; 294: 929-31.
537. Browse NL. Diseases of the heart and blood vessels: ischaemia of the lower limbs. BMJ 1996; ii: 157-9.
538. Humphreys ML, Stewart AH, Gohel MS et al. Management of mixed arterial and venous ulcers Br J Surg 2007; 94: 1104-7.
539. Hafner J, Schaad I, Schneider E et al. Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol 2000; 43: 1001-8.
540. Kavros SJ, Delis KT, Turner NS et al. Improving limb salvage in critical ischaemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg 2008; 47: 543-9.
541. Nelson EA, Bradley MD. Dressings and topical agents for arterial leg ulcers. Cochrane Database Sys Rev 2007; CD001836.
542. Martorell F. Hypertensive ulcer of the leg. Angiology 1950; 1: 133-40.
543. Alberti JMZ. Hypertensive ulcers: Martorell's ulcer. Phlebology 1988; 3: 139-42.
544. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens 2001; 15: 279-83.
545. Leu HJ. Hypertensive ischaemic leg ulcer (Martorell's ulcer): a specific disease entity? Int Angiol 1992; 11: 132-6.
546. Viglio S, Annovazzi L, Conti B et al. The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach. J Chromatogr B 2006; 832: 1-8.
547. Trent J, Kirsner RS. Leg ulcers secondary to prolidase deficiency. Adv Skin Wound Care 2004; 17: 468-72.
548. Kokturk A, Kaya TI, Ikizoglu G, Koca A. Prolidase deficiency. Int J Dermatol 2002; 41: 46-8.
549. Milligan A, Graham-Brown RAC, Burns DA et al. Prolidase deficiency: a case report and literature review. Br J Dermatol 1989; 121: 405-9.
550. Buist NRM, Strandholm JJ, Bellinger JF et al. Further studies on a patient with iminodipeptiduria: a probable case of prolidase deficiency. Metabolism 1972; 21: 1113-23.
551. Jemec, GBE, Moe ATT. Topical treatment of skin ulcers in prolidase deficiency. Pediatr Dermatol 1996; 13: 58-60.
552. Arata J, Hatakenaka K, Oono T. Effect of topical application of glycine and proline on recalcitrant leg ulcers of prolidase deficiency. Arch Dermatol 1986; 122: 626-7.
553. Lupi A, Casado B, Soli M et al. Therapeutic apheresis exchange in two patients with prolidase deficiency. Br J Dermatol 2002; 147: 1237-40.
554. Monafo V, Marseglia GL, Maghnie M et al. Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency. Pediatr Dermatol 2000; 17: 227-30.
555. Sirieix M-E, Debure C, Baudot N et al. Leg ulcers and hydroxyurea. Arch Dermatol 1999; 135: 818-20.
556. Bader U, Banyai M, Burg G, Hafner J. Leg ulcers in patients with myeloproliferative disorders: disease-or treatment-related? Dermatology 2000; 200: 45-8.
557. Vassallo C, Passamonti F, Merante S et al. Mucocutaneous changes during longterm therapy with hydroxyurea in chronic myeloid leukemia. Clin Exp Dermatol 2001; 26: 141-8.
558. Najean Y, Rain JD. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997; 90: 3370-7.
559. Best PJ, Daoud MS, Pittelkow MR, Petitt RM. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 1998; 128: 29-32.
560. Allison JH, Bettley FR. Rheumatoid arthritis with chronic leg ulceration. Lancet 1957; i: 288-90.
561. Goslen JB. Autoimmune ulceration of the leg. Clin Dermatol 1990; 8: 92-117.
562. Poonawalla T, Colome-Grimmer MI, Kelly B. Ulcerative sarcoidosis in the legs with granulomatous vasculitis. Clin Exp Dermatol 2008; 33: 282-6.
563. Williamson AE, Cone LA, Huard GS. Spontaneous necrosis of the skin associated with cryofibrinogenaemia, cryoglobulinaemia and homocysteinaemia. Ann Vasc Surg 1996; 10: 365-9.
564. Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006; 142: 1413-8.
565. Mimouni D, Ng PP, Rencic A et al. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 2003; 148: 789-94.
566. Pascher F, Keen R. Ulcers of the leg in Cooley's anemia. N Engl J Med 1957; 256: 1220-2.
567. Koshy M, Entsuah R, Koranda A et al. Leg ulcers in patients with sickle cell disease. Blood 1989; 74: 1403-8.
568. Clare A, Fitzhenley M, Harris J et al. Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence. Br J Haematol 2002; 119: 567-71.
569. Sawhney H, Weedon J, Gillette P et al. Predilection of haemolytic anaemia-associated leg ulcers for the medial malleolus. Vasa 2002; 31: 191-3.
570. Bjornberg A, Hellgren L. Necrosis in leg ulcers: probable role of fluocinolone acetonide. Arch Dermatol 1965; 92: 52-3.
571. Callen JP. Pyoderma gangrenosum. Lancet 1998; 351: 581-5.
572. Su WP, Davis MD, Weenig RH et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004; 30: 790-800.
573. Chan CL, Meyer FJ, Hay RJ et al. The ulceration associated with compression bandaging: observational study. BMJ 2001; 323: 1099.
574. Burden AC, Jones CR, Jones R et al. Use of the 'Scotchcast boot' in treating diabetic foot ulcers. BMJ 1983; 286: 1555-7.
575. Boulton AJ. Pressure and the diabetic foot: clinical science and offloading techniques. Am J Surg 2004; 187: 17S-24S.
576. Edmonds M. Diabetic foot ulcers: practical treatment recommendations. Drugs 2006; 66: 913-29.
577. Rao N, Lipsky BA. Optimising antimicrobial therapy in diabetic foot infections. Drugs 2007; 67: 195-214.
578. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366: 1725-35.